Dysport® Adult Upper Limb Spasticity
Public ClinicalTrials.gov record NCT01313299. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Multicentre, Prospective, Double Blind, Randomised, Placebo Controlled Study, Assessing the Efficacy and Safety of Dysport® Intramuscular Injections Used for the Treatment of Upper Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Study identification
- NCT ID
- NCT01313299
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Ipsen
- Industry
- Enrollment
- 243 participants
Conditions and interventions
Conditions
Interventions
- Botulinum toxin type A Biological
- Placebo Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2011
- Primary completion
- Aug 31, 2013
- Completion
- Aug 31, 2013
- Last update posted
- Sep 27, 2022
2011 – 2013
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rancho Los Amigos National Rehabilitation Center | Downey | California | 90242 | — |
| Associated Neurologist of Southern CT, PT | Fairfield | Connecticut | 06824 | — |
| Parkinson's Disease & Movement Disorders Center of Boca Raton | Boca Raton | Florida | 33488 | — |
| Design Neuroscience Miami | South Miami | Florida | 33169 | — |
| The Rehabilitation Institute of Chicago | Chicago | Illinois | 60611 | — |
| Mount Sinai School of Medicine | New York | New York | 10029-6574 | — |
| Weill Cornell Medical College | New York | New York | 10065 | — |
| Univ of North Carolina - Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Wake Forest Medical Center | Winston-Salem | North Carolina | 27157 | — |
| Vanderbilt University | Nashville | Tennessee | 37232 | — |
| University of Texas | Dallas | Texas | 75080 | — |
| Southwestern Medical Center at Dallas | Dallas | Texas | 75390 | — |
| University of North Texas HSC | Fort Worth | Texas | 76104 | — |
| University of Texas | Houston | Texas | 77030 | — |
| University of Utah School of Medicine | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01313299, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2022 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01313299 live on ClinicalTrials.gov.